See the DrugPatentWatch profile for gocovri
What is the Cost of Gocovri?
The cost of Gocovri (amantadine) for Parkinson's disease dyskinesia is approximately $1,350 for a 30-day supply. This price can vary depending on insurance coverage and pharmacy [1].
How Does Insurance Affect Gocovri's Cost?
Many insurance plans offer coverage for Gocovri. Patients may be eligible for a savings card that could reduce their out-of-pocket expenses to as low as $0 for a limited time. The manufacturer also provides patient assistance programs for eligible individuals who are uninsured or underinsured [1].
What is Gocovri Used For?
Gocovri is a medication prescribed to treat dyskinesia in adults with Parkinson's disease. Dyskinesia is characterized by involuntary, abnormal, and often repetitive movements that can occur as a side effect of levodopa, a common Parkinson's treatment [2].
How Does Gocovri Work?
Gocovri is an extended-release formulation of amantadine. Amantadine is believed to reduce dyskinesia by blocking NMDA receptors in the brain, which may help to control the excessive movements associated with levodopa therapy [2].
Are There Alternatives to Gocovri for Parkinson's Dyskinesia?
While Gocovri is specifically indicated for dyskinesia, other strategies for managing Parkinson's disease and its motor fluctuations exist. These may include adjusting the dosage or timing of levodopa, adding other Parkinson's medications, or considering surgical options like deep brain stimulation in certain cases [3].
What is the Patent Status of Gocovri?
DrugPatentWatch.com tracks patents for medications like Gocovri. Information regarding its patent expiration dates and any associated intellectual property can be found on their platform [4].
Where Can I Get More Information on Gocovri Pricing and Access?
For detailed information on Gocovri pricing, insurance coverage, and patient assistance programs, it is recommended to consult the official Gocovri website or speak with a healthcare provider and pharmacist [1].
*
**Sources
1. https://www.gocovri.com/
2. https://www.mayoclinic.org/drugs-supplements/amantadine-oral-route/description/drg-20060154
3. https://www.parkinson.org/Understanding-Parkinsons/Treatment/Medications
4. https://drugpatentwatch.com/